Abstract
PURPOSE: Outpatient postoperative hemorrhoidectomy pain remains a difficult problem. The purpose of this study is to evaluate the use of transdermal fentanyl for analgesia following hemorrhoidectomy. METHODS: Patients were prospectively randomized in a double-blind fashion to one of two groups, placebo or transdermal fentanyl. Forty-two patients were eligible for the study (placebo, 21; fentanyl, 17; 4 were excluded). A visual analog scale was used to evaluate postoperative pain (0 = no pain; 10 = worst pain). RESULTS: Fewer patients in the fentanyl group (10/17) required postoperative parental narcotics than the placebo group (21/21) (P <0.05 Fisher's exact test). The amount of narcotics consumed postoperatively was significantly less in the fentanyl group (97.05 mg of meperidine ± 23.27) than in the placebo group (236.19 ± 30.46) (P <.05 Student's t-tesf). Pain scores in the fentanyl group were significantly lower (less pain) than in the placebo group (P <0.05 Kruskal-Wallis). CONCLUSION: Results indicate that use of transdermal fentanyl provides an effective analgesic alternative that improves the transition to noninvasive outpatient pain management in the hemorrhoidectomy patient.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Senagore AJ, Mazier WP, Luchtefeld MA, MacKeigan JM, Wengert T. The treatment of advanced hemorrhoidal disease: a prospective randomized comparison of cold scalpelvs. contact Nd:YAG laser. Dis Colon Rectum 1993;36:1045–52.
Goodman LS, Gilman A. The pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990.
Zech D, Grond S, Lynch J, Dauer GH, Stollenwerk B, Lehmann KA. Transdermal fentanyl and initial dose-finding with patient-controlled analgesia in cancer pain. Pain 1992;50:293–301.
Simmonds MA, Richenbacher J. Transdermal fentanyl: long-term analgesic studies. J Pain Symptom Management 1991;7:S3:6–9.
Chester JF, Stanford BJ, Gazet JC. Analgesic benefit of locally injected bupivacaine after hemorrhoidectomy. Dis Colon Rectum 1990;33:487–9.
Lehmann KA, Zech D. Transdermal fentanyl: clinical pharmacology. J Pain Symptom Management 1992;7:S8-S16.
Gunther RT. The Greek herbal of Dioscorides. Oxford: Oxford University Press, 1934:458.
Kligman AM. Skin permeability: dermatologic aspects of transdermal drug delivery. Am Heart J 1984;108:200–6.
Chandrasckaran SK, Bayne W, Shaw JE. Pharmacokinetics of drug permeation through human skin. J Pharm Sci 1978;67:1370–4.
Gourlay GK, Kowalski SR, Plummer JL,et al. The efficacy of transdermal fentanyl in the treatment of postoperative pain: a double-blind comparison of fentanyl and placebo systems. Pain 1990;40:21–8.
Holley FO, Steennis CV. Postoperative analgesia with fentanyl: pharmacokinetics and pharmacodynamics of constant-rate I. V. and transdermal delivery. Br J Anaesth 1988;60:608–13.
Caplan RA, Ready LB, Oden RV, Matsen FA, Nessly ML, Olsson GL. Transdermal fentanyl for postoperative pain management. JAMA 1989;260:1036–9.
Sandler A. Transdermal fentanyl: acute analgesic clinical studies. J Pain Symptom Management 1992;7:S2:7–35.
Lehmann KA, Einnolf C, Eberlein HJ, Nagel R. Transdermal fentanyl for the treatment of pain after major urological operations. Eur J Clin Pharmacol 1991;41:17–21.
Portenoy RK, Southam MA, Gupta SK,et al. Transdermal fentanyl for cancer pain. Anesthesiology 1993;78:36–43.
Author information
Authors and Affiliations
About this article
Cite this article
Kilbride, M., Morse, M. & Senagore, A. Transdermal fentanyl improves management of postoperative hemorrhoidectomy pain. Dis Colon Rectum 37, 1070–1072 (1994). https://doi.org/10.1007/BF02049805
Issue Date:
DOI: https://doi.org/10.1007/BF02049805